Acrivon TherapeuticsACRV
13F holders, Q1 2024 (March 31)48holders
3famous investors
$7.15avg. 13F price*
At the end of Q1 2024, 48 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($34.4M), Perceptive Advisors LLC ($21.5M) and Citadel Advisors ($12.0M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $2.1M |
| Exits | 6 | $2.9M |
Ownership 48 holders
| Ra Capital Management, L.P. | 0.44% | No change | 4,810,508 | $34.4M |
| Perceptive Advisors LLC | 0.38% | No change | 3,007,858 | $21.5M |
| Citadel Advisors | 0.01% | Add +1.8% | 1,680,027 | $12.0M |
| Sands Capital Alternatives, LLC | 2.85% | No change | 1,652,605 | $11.8M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $6.4M |
| BlackRock Inc. | 0.00% | Add +31.5% | 743,901 | $5.3M |
| Marshall Wace, LLP | 0.01% | No change | 597,469 | $4.3M |
| Vanguard Group Inc. | 0.00% | Add +6.6% | 507,185 | $3.6M |
| Geode Capital Management, LLC | 0.00% | Add +28.4% | 242,846 | $1.7M |
| State Street Corp. | 0.00% | No change | 133,276 | $953K |
| DAFNA Capital Management LLC | 0.22% | No change | 131,351 | $939K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.03% | Add +35.9% | 126,949 | $908K |
| Northern Trust Corp. | 0.00% | Add +34.4% | 107,750 | $770K |
| Renaissance Technologies | 0.00% | New | 102,600 | $734K |
| Millennium Management | 0.00% | New | 95,497 | $683K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +13.0% | 77,382 | $553K |
| Bridgeway Capital Management, LLC | 0.01% | Add +81.9% | 58,181 | $416K |
| Exchange Traded Concepts, LLC | 0.01% | Add +322.9% | 56,200 | $402K |
| Baker Bros. Advisors LP | 0.00% | New | 52,885 | $378K |
| Bank of New York Mellon Corp | 0.00% | Reduce -1.5% | 24,413 | $175K |
| Barclays PLC | 0.00% | Reduce -12.9% | 21,324 | $152K |
| Morgan Stanley | 0.00% | Reduce -32.7% | 17,243 | $123K |
| Prelude Capital Management, LLC | 0.01% | New | 13,000 | $93K |
| UBS Group AG | 0.00% | New | 12,745 | $91K |
| Nuveen Asset Management, LLC | 0.00% | No change | 11,821 | $85K |
| Rhumbline Advisers | 0.00% | Add +17.5% | 10,889 | $78K |
| AAF Wealth Management, LLC | 0.04% | No change | 10,678 | $76K |
| Raymond James & Associates | 0.00% | New | 10,200 | $73K |
| Bank of America Corp. | 0.00% | Reduce -40.1% | 6,039 | $43K |
| American International Group, Inc. | 0.00% | Add +39.2% | 6,016 | $43K |
| Osaic Holdings, Inc. | 0.00% | New | 5,080 | $36K |
| JPMorgan Chase & Co. | 0.00% | Reduce -85.1% | 4,959 | $35K |
| Citigroup Inc. | 0.00% | Add +121.6% | 4,536 | $32K |
| Wells Fargo & Company | 0.00% | Add +59.8% | 4,299 | $31K |
| New York State Common Retirement Fund | 0.00% | No change | 2,273 | $16K |
| California State Teachers Retirement System | 0.00% | Reduce -14.3% | 1,227 | $9K |
| Catalyst Funds Management Pty Ltd | 0.00% | — | 1,044 | $7K |
| FMR LLC | 0.00% | Add +27.4% | 1,027 | $7K |
| Legal & General Group Plc | 0.00% | No change | 839 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -59.5% | 817 | $6K |
| STRS Ohio | 0.00% | No change | 800 | $5K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 695 | $5K |
| Amalgamated Bank | 0.00% | Reduce -69.3% | 378 | $3K |
| Royal Bank of Canada | 0.00% | Reduce -88.8% | 278 | $2K |
| Russell Investments Group, Ltd. | 0.00% | New | 223 | $2K |
| Avion Wealth | 0.00% | New | 88 | $1K |
| Cwm, LLC | 0.00% | New | 3 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | New | 48 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.